General Information of Drug Formulation (ID: F23428)

Formulation Name
Dolutegravir Sodium eq 5mg base tablet for suspension
Company
Viiv Hlthcare
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Dolutegravir DMCZGRE Human immunodeficiency virus infection 1C62 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Calcium sulfate dihydrate E00315 24928 Desiccant; Diluent
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Crospovidone E00626 Not Available Disintegrant
Hypromellose E00634 Not Available Coating agent
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 4000 E00654 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Sodium stearyl fumarate E00545 23665634 lubricant
Sucralose E00370 71485 Flavoring agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent